Trusted Global Manufacturer of High-Quality Anti-Retroviral Medicines

India has emerged as the global hub for anti-retroviral (ARV) medicine manufacturing, supplying life-saving therapies to governments, NGOs, hospitals, and international procurement agencies worldwide. At the forefront of this critical healthcare mission stands Taj Pharma Limited, a globally recognized pharmaceutical manufacturer with over 30+ years of industry expertise and a robust presence across 85+ countries.

We are committed to delivering safe, effective, and affordable anti-retroviral medicines that meet the highest international quality standards. Our advanced manufacturing infrastructure, regulatory excellence, and deep therapeutic expertise position us as a preferred anti-retroviral medicine manufacturer in India for regulated and semi-regulated markets.


Why Taj Pharma is a Leading Anti-Retroviral Manufacturer in India

Our success is built on a foundation of quality, compliance, innovation, and scale. We operate state-of-the-art facilities approved by US-FDA, UK-MHRA, EU-GMP, and WHO-GMP, enabling us to serve both highly regulated and emerging markets seamlessly.

Key Strengths at a Glance

  • 30+ years of pharmaceutical manufacturing excellence
  • Global exports to 85+ countries
  • US-FDA, UK-MHRA, EU-GMP, WHO-GMP certified facilities
  • Comprehensive ARV portfolio covering first-line, second-line, and third-line therapies
  • High-volume manufacturing with assured supply continuity
  • Strong focus on cost optimization and affordability

Comprehensive Anti-Retroviral Product Portfolio

We manufacture a broad spectrum of WHO-recommended anti-retroviral formulations, including NRTIs, NNRTIs, Protease Inhibitors, Integrase Inhibitors, and fixed-dose combinations (FDCs) used in HAART regimens.

ANTI-RETROVIRAL PRODUCT LIST (STANDARD FORMAT)

Generic NameDosage FormAvailable StrengthsTherapeutic CategoryBCS Class (Estimate)
Emtricitabine + Tenofovir Disoproxil FumarateTablet200 mg / 300 mgAntiretroviral (NRTI Combination)Class I / III
EtravirineTablet200 mgAntiretroviral (NNRTI)Class II
Efavirenz + Tenofovir DF + LamivudineTablet600 mg / 300 mg / 300 mgAntiretroviral (HAART Combination)Class II / III
Lopinavir + RitonavirTablet200 mg / 50 mgAntiretroviral (Protease Inhibitor)Class II
Tenofovir Disoproxil FumarateTablet300 mgAntiretroviral (NRTI)Class III
RaltegravirTablet400 mgAntiretroviral (Integrase Inhibitor)Class II
SofosbuvirTablet400 mgAntiviral (HCV)Class I
Sofosbuvir + LedipasvirTablet400 mg / 90 mgAntiviral (HCV Combination)Class I / II
Sofosbuvir + VelpatasvirTablet400 mg / 100 mgAntiviral (HCV Combination)Class I / II
EntecavirTablet0.5 mgAntiviral (HBV)Class III
EntecavirTablet1 mgAntiviral (HBV)Class III
DaclatasvirTablet60 mgAntiviral (HCV NS5A Inhibitor)Class II
DolutegravirTablet50 mgAntiretroviral (Integrase Inhibitor)Class II
EfavirenzTablet600 mgAntiretroviral (NNRTI)Class II
Efavirenz + Emtricitabine + Tenofovir DFTablet600 mg / 200 mg / 300 mgAntiretroviral (HAART Combination)Class II / III
Darunavir + RitonavirTablet800 mg / 100 mgAntiretroviral (Protease Inhibitor)Class II
Tenofovir AlafenamideTablet25 mgAntiretroviral (NRTI)Class III
Dolutegravir + Emtricitabine + Tenofovir AlafenamideTablet50 mg / 200 mg / 25 mgAntiretroviral (HAART Combination)Class II / III
LamivudineTablet100 mgAntiretroviral / Antiviral (NRTI)Class III
Lamivudine + StavudineTablet150 mg / 30 mgAntiretroviral (NRTI Combination)Class III
Lamivudine + ZidovudineTablet150 mg / 300 mgAntiretroviral (NRTI Combination)Class III
Lamivudine + Nevirapine + StavudineTablet150 mg / 200 mg / 30 mgAntiretroviral (HAART Combination)Class II / III
Lamivudine + Zidovudine + NevirapineTablet150 mg / 300 mg / 200 mgAntiretroviral (HAART Combination)Class II / III
Atazanavir + RitonavirTablet300 mg / 100 mgAntiretroviral (Protease Inhibitor)Class II
Lopinavir + RitonavirTablet200 mg / 50 mgAntiretroviral (Protease Inhibitor)Class II
RitonavirTablet50 mgAntiretroviral (Protease Inhibitor)Class II
RitonavirTablet100 mgAntiretroviral (Protease Inhibitor)Class II
DarunavirTablet800 mgAntiretroviral (Protease Inhibitor)Class II

This extensive portfolio allows us to support national HIV/AIDS control programs, PEPFAR tenders, Global Fund supplies, and private-label distribution globally.


World-Class Manufacturing Capabilities

Unit 1 – Sarigam (Emerging Markets)

Our Sarigam facility is optimized for high-volume, cost-efficient production while maintaining uncompromising quality standards.

  • WHO-GMP certified
  • DIGEMID Peru approved
  • ISO 9000:2015 certified
  • EU-GMP audit triggered (targeted completion by FY 2026)
  • 500+ formulations across tablets, capsules, liquids, and powders

This unit is ideally suited for government tenders, NGO supply chains, and large-volume international procurement.


Unit 2 – Viramgam (Regulated Markets)

Designed to meet the most stringent global regulations, our Viramgam facility caters to highly regulated markets.

  • US-FDA approved
  • UK-MHRA accredited
  • EU-GMP compliant
  • Current capacity:
    • 1.2 billion tablets per annum
    • 500 million capsules per annum
  • Expansion-ready:
    • Up to 1.5 billion tablets
    • 0.5 billion capsules

This facility supports ANDA filings, regulated-market exports, and complex ARV formulations.


Advanced R&D for Anti-Retroviral Excellence

Our dedicated R&D Centre, staffed by 25+ experienced scientists, plays a pivotal role in strengthening our ARV portfolio. We specialize in:

  • Formulation optimization
  • Bioequivalence-driven product development
  • Cost of Goods Sold (COGS) reduction
  • Process scale-up and validation
  • Technology transfer for global partners

Our scientific focus enables partners to achieve faster time-to-market, competitive pricing, and sustainable long-term supply.


Flexible Global Collaboration Models

Through our innovation-driven arm, Stallion Labs, we offer customized collaboration frameworks to meet diverse business objectives.

CMO – Contract Manufacturing Organization

We provide seamless, high-quality manufacturing support aligned with your supply chain requirements.

CDMO – Contract Development & Manufacturing Organization

From development to commercialization, we support the complete product lifecycle.

Co-Development & In-Licensing

We actively engage in joint development programs and in-licensing of differentiated anti-retroviral assets.

These models are designed to help partners optimize investments, reduce risks, and scale efficiently.


Quality, Compliance, and Global Trust

Quality is embedded at every stage of our operations. Our ARV products undergo rigorous quality control, stability testing, and regulatory compliance checks to ensure consistent performance across global markets.

We comply with:

  • ICH Guidelines
  • WHO Prequalification requirements
  • Country-specific regulatory dossiers
  • Pharmacovigilance and post-marketing surveillance

This unwavering commitment has earned us long-term trust among health ministries, procurement agencies, and multinational partners.


Serving Global HIV/AIDS Programs with Reliability

We understand the critical importance of uninterrupted ARV supply. Our robust production planning, dual sourcing strategies, and inventory controls ensure reliable delivery even in high-demand scenarios.

Our medicines contribute to:

  • Improved patient adherence
  • Reduced viral resistance
  • Expanded access to affordable HIV treatment

Partner with a Proven Anti-Retroviral Manufacturer in India

As a trusted anti-retroviral medicine manufacturer in India, we combine scale, science, compliance, and cost efficiency to deliver sustainable healthcare solutions worldwide. Whether your requirement is bulk supply, regulated-market exports, or strategic collaboration, we offer the expertise and infrastructure to support your success.